Nonseminomatous germ cell tumors: Assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis

Journal of Thoracic and Cardiovascular Surgery

Volumn 137, Issue 2, 2009, Pages 448-452

  Besse, Benjamin ^a   Grunenwald, Dominique ^b   Fléchon, Aude ^c   Caty, Armelle ^d   Chevreau, Christine ^e   Culine, Stéphane ^f   Théodore, Christine ^g   Fizazi, Karim ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b HÔPITAL TENON   (France)

^c CENTRE LÉON BÉRARD   (France)

^d CENTRE OSCAR LAMBRET   (France)

^e INSTITUT CLAUDIUS REGAUD   (France)

^f CENTRE VAL D AURELLE   (France)

^g FOCH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BLEOMYCIN; CHORIONIC GONADOTROPIN; CISPLATIN; ETOPOSIDE; LACTATE DEHYDROGENASE; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FEMALE; GERM CELL TUMOR; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG METASTASIS; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NON SEMINOMATOUS GERMINOMA; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TERATOMA; TISSUE NECROSIS; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CHORIOCARCINOMA; CISPLATIN; ENDODERMAL SINUS TUMOR; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MEDIASTINAL NEOPLASMS; NECROSIS; NEOPLASMS, GERM CELL AND EMBRYONAL; PNEUMONECTOMY; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; TERATOMA; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 58649092197     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.09.032     Document Type: Article

References (25)

1. Bosl G.J., and Motzer R.J. Testicular germ-cell cancer. N Engl J Med 337 (1997) 242-253
2. Schmoll H.J., Souchon R., Krege S., Albers P., Beyer J., Kollmannsberger C., et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15 (2004) 1377-1399
3. Fizazi K., Culine S., Kramar A., Amato R.J., Bouzy J., Chen I., et al. Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors. J Clin Oncol 22 (2004) 3868-3876
4. Fizazi K., Tjulandin S., Salvioni R., Germa-Lluch J.R., Bouzy J., Ragan D., et al. Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy-results from an international study group. J Clin Oncol 19 (2001) 2647-2657
5. Fizazi K., Oldenburg J., Dunant A., Chen I., Salvioni R., Hartmann J.T., et al. Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study. Ann Oncol 19 (2008) 259-264
6. Fossa S.D., Aass N., Ous S., Hoie J., Stenwig A.E., Lien H.H., et al. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer. J Urol 142 (1989) 1239-1242
7. Germa-Lluch J.R., Garcia Dm X., Maroto P., Paz-Ares L., Arranz J.A., Guma J., et al. Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG). Eur Urol 42 (2002) 553-562
8. McGuire M.S., Rabbani F., Mohseni H., Bains M., Motzer R., and Sheinfeld J. The role of thoracotomy in managing postchemotherapy residual thoracic masses in patients with nonseminomatous germ cell tumours. BJU Int 91 (2003) 469-473
9. Rasmussen O.V., Daugaard G., Christiansen S., Sorensen B.L., and Rorth M. Secondary surgery in patients with malignant germ cell tumors. J Urol 147 (1992) 393-397
10. Steyerberg E.W., Keizer H.J., Fossa S.D., Sleijfer D.T., Toner G.C., Schraffordt K.H., et al. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol 13 (1995) 1177-1187
11. Steyerberg E.W., Keizer H.J., Messemer J.E., Toner G.C., Schraffordt K.H., Fossa S.D., et al. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group. Cancer 79 (1997) 345-355
12. Steyerberg E.W., Gerl A., Fossa S.D., Sleijfer D.T., de Wit R., Kirkels W.J., et al. Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer. J Clin Oncol 16 (1998) 269-274
13. Toner G.C., Panicek D.M., Heelan R.T., Geller N.L., Lin S.Y., Bajorin D., et al. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol 8 (1990) 1683-1694
14. Hartmann J.T., Candelaria M., Kuczyk M.A., Schmoll H.J., and Bokemeyer C. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours. Eur J Cancer 336 (1997) 843-847
15. Skinner D.G., Melamud A., and Lieskovsky G. Complications of thoracoabdominal retroperitoneal lymph node dissection. J Urol 127 (1982) 1107-1110
16. Kesler K.A., Brooks J.A., Rieger K.M., Fineberg N.S., Einhorn L.H., and Brown J.W. Mediastinal metastases from testicular nonseminomatous germ cell tumors: patterns of dissemination and predictors of long-term survival with surgery. J Thorac Cardiovasc Surg 125 (2003) 913-923
17. Tognoni P.G., Foster R.S., McGraw P., Heilman D., Bihrle R., Rowland R.G., et al. Combined post-chemotherapy retroperitoneal lymph node dissection and resection of chest tumor under the same anesthetic is appropriate based on morbidity and tumor pathology. J Urol 159 (1998) 1833-1835
18. Liu D., Abolhoda A., Burt M.E., Martini N., Bains M.S., Downey R.J., et al. Pulmonary metastasectomy for testicular germ cell tumors: a 28-year experience. Ann Thorac Surg 66 (1998) 1709-1714
19. Agero A.L., Dusza S.W., Benvenuto-Andrade C., Busam K.J., Myskowski P., and Halpern A.C. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol 55 (2006) 657-670
20. Motzer R.J., Amsterdam A., Prieto V., Sheinfeld J., Murty V.V., Mazumdar M., et al. Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol 159 (1998) 133-138
21. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15 (1997) 594-603
22. Andre F., Fizazi K., Culine S., Droz J., Taupin P., Lhomme C., et al. The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients. Eur J Cancer 361 (2000) 1389-1394
23. Putra L.J., Lawrentschuk N., Ballok Z., Hannah A., Poon A., Tauro A., et al. 18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy. Urology 64 (2004) 1202-1207
24. Kollmannsberger C., Oechsle K., Dohmen B.M., Pfannenberg A., Bares R., Claussen C.D., et al. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma. Cancer 94 (2002) 2353-2362
25. Sugimura J., Foster R.S., Cummings O.W., Kort E.J., Takahashi M., Lavery T.T., et al. Gene expression profiling of early- and late-relapse nonseminomatous germ cell tumor and primitive neuroectodermal tumor of the testis. Clin Cancer Res 10 (2004) 2368-2378